Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.22 - $18.82 $29,609 - $77,180
-4,101 Reduced 1.09%
370,899 $2.77 Million
Q1 2024

May 15, 2024

BUY
$16.79 - $25.38 $3.78 Million - $5.71 Million
225,000 Added 150.0%
375,000 $6.4 Million
Q4 2023

Feb 14, 2024

BUY
$12.21 - $23.36 $1.83 Million - $3.5 Million
150,000 New
150,000 $3.41 Million
Q1 2022

May 16, 2022

SELL
$1.68 - $3.92 $226,800 - $529,200
-135,000 Closed
0 $0
Q4 2021

Feb 16, 2022

BUY
$3.36 - $14.64 $117,600 - $512,400
35,000 Added 35.0%
135,000 $512,000
Q3 2021

Nov 15, 2021

BUY
$7.0 - $12.5 $700,000 - $1.25 Million
100,000 New
100,000 $1.22 Million

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $79.5M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.